Salmany Sewar S, Ratrout Lujeen, Amireh Abdallah, Agha Randa, Nassar Noor, Mahmoud Nour, Rimawi Dalia, Nazer Lama
1 Department of Pharmacy, King Hussein Cancer Center, Amman, Jordan.
2 Office of Scientific Affairs and Research, King Hussein Cancer Center, Amman, Jordan.
J Oncol Pharm Pract. 2018 Jul;24(5):359-364. doi: 10.1177/1078155217709616. Epub 2017 May 16.
Purpose The aim of the study was to determine the impact of telephone follow-up calls on satisfaction in oncology patients after hospital discharge. Method A randomized controlled study, in which patients were randomized into two groups: The experimental group with the telephone follow-up (TFU) calls (intervention) and the control group (no intervention). The telephone follow-up call was conducted within 72 h after discharge. During the call, patients were asked about their medications, namely, whether they received them, understood how to take them, and whether they developed any medication-related adverse effect. Both groups were contacted by phone two weeks later to assess their satisfaction with the discharge medication instructions and the provided pharmaceutical services, using the 5-point Likert scale. In addition, hospital records were reviewed for emergency room visits and hospital readmissions within 30 days after discharge. Results There was no difference in the percentage of patients who reported being very satisfied between both the intervention and the control groups (45% intervention vs. 48% control, P = 0.68). The mean time of the intervention phone call was 3 ± 1.7 (SD) min. During the telephone follow-up call, medication-related problems were identified in 20% of the patients. There was no significant difference in emergency room visits and hospital readmissions in the intervention group vs. control (44% vs. 53%, P = 0.123) and (37% vs. 43%, P = 0.317), respectively. Conclusion Telephone follow-up calls conducted by a pharmacist to discharged oncology patients did not improve patients' satisfaction, emergency room visits or hospital readmissions; however, they helped to identify medication-related adverse effects in the oncology patients.
本研究旨在确定出院后电话随访对肿瘤患者满意度的影响。方法:一项随机对照研究,患者被随机分为两组:接受电话随访(TFU)呼叫的实验组(干预组)和对照组(无干预)。出院后72小时内进行电话随访。在通话过程中,询问患者关于他们的药物,即是否服用了药物、是否理解如何服用以及是否出现任何与药物相关的不良反应。两周后通过电话联系两组患者,使用5分李克特量表评估他们对出院用药指导和所提供药学服务的满意度。此外,查阅出院后30天内的医院记录,了解急诊就诊和再次入院情况。结果:干预组和对照组中报告非常满意的患者百分比没有差异(干预组45% vs. 对照组48%,P = 0.68)。干预电话的平均时长为3 ± 1.7(标准差)分钟。在电话随访过程中,20%的患者被发现存在与药物相关的问题。干预组与对照组在急诊就诊和再次入院方面没有显著差异,分别为(干预组44% vs. 对照组53%,P = 0.123)和(干预组37% vs. 对照组43%,P = 0.317)。结论:药剂师对出院肿瘤患者进行的电话随访并没有提高患者的满意度、急诊就诊率或再次入院率;然而,它们有助于识别肿瘤患者中与药物相关的不良反应。